Intelligent Bio Solutions Inc. Asset Resilience Ratio
Intelligent Bio Solutions Inc. asset resilience ratio. Intelligent Bio Solutions Inc. (INBS) has an Asset Resilience Ratio of 0.81% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See INBS cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Intelligent Bio Solutions Inc. (2023–2023)
Asset resilience ratio of Intelligent Bio Solutions Inc. from 2023 to 2023. This chart shows how Intelligent Bio Solutions Inc.'s Asset Resilience Ratio has changed over time. Read total liabilities of Intelligent Bio Solutions Inc. for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Intelligent Bio Solutions Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Intelligent Bio Solutions Inc.'s balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $111.19K | 0.81% |
| Total Liquid Assets | $111.19K | 0.81% |
Asset Resilience Insights
- Limited Liquidity: Intelligent Bio Solutions Inc. maintains only 0.81% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Intelligent Bio Solutions Inc. Industry Peers by Asset Resilience Ratio
Compare Intelligent Bio Solutions Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Intelligent Bio Solutions Inc. Asset Resilience Ratio by Year (2023–2023)
Intelligent Bio Solutions Inc. asset resilience ratio by year from 2023 to 2023. The table below shows the annual Asset Resilience Ratio data for Intelligent Bio Solutions Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-06-30 | 0.45% | $46.60K | $10.35 Million | -- |
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The compan… Read more